We are live on ! Find out more
FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
+16.33%
1 Year Est. Return
+151.58%
3 Year Est. Return
+408.4%
5 Year Est. Return
+1,802.6%
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$37.1M
Cap. Flow
-$36.7M
Cap. Flow %
-29.24%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$4.87M

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$40.2M
2
FOLD
Amicus Therapeutics
FOLD
+$1.35M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBRA
1
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$33.5M 26.73%
2,668,570
– –
GKOS icon
2
Glaukos
GKOS
$10.7B
$25.3M 20.18%
867,788
-1,735,574
-67% -$40.2M
COLL icon
3
Collegium Pharmaceutical
COLL
$820M
$22.4M 17.84%
1,887,332
– –
FOLD
4
DELISTED
Amicus Therapeutics
FOLD
$14.9M 11.87%
2,725,591
-192,700
-7% -$1.35M
CDTX
5
DELISTED
Cidara Therapeutics
CDTX
$13.5M 10.79%
65,613
– –
IOVA icon
6
Iovance Biotherapeutics
IOVA
$3.74B
$6.28M 5.01%
+774,720
New +$4.87M
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
$5.15M 4.11%
950,366
– –
SRRA
8
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.35M 3.47%
54,655
– –

Similar funds

ACMV
August Capital Management VI Palo Alto, California $1.39M AUM
FRCMI
First Round Capital Management III Philadelphia, Pennsylvania $418K AUM
DB
DCVC Bio Palo Alto, California $313K AUM
NAM
Newfleet Asset Management Hartford, Connecticut $2.05M AUM 27.28% 1-Year Est. Return
AP
Atlas Principals Charlotte, North Carolina $2.19M AUM 56.71% 1-Year Est. Return
ID
Inspire Developers Forest Hills, New York $4.07M AUM
CI
CMT Investments Chicago, Illinois $5M AUM 15.27% 1-Year Est. Return
DIF
Discovery Investment Fund Singapore $6.98M AUM

Frazier Management's Q2 2016 Portfolio in Review

As of Q2 2016, Frazier Management held 8 positions worth $125M, down 23% from $162M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Frazier Management withdrew a net $36.7M in Q2 2016, reducing 2 holdings. Its largest reduction was Glaukos, cutting an estimated $40.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Frazier Management opened a new position in Iovance Biotherapeutics worth $6.28M.

  • Frazier Management's largest Q2 2016 buy was Iovance Biotherapeutics: 774,720 shares worth $6.28M.
  • Frazier Management's biggest Q2 2016 reduction was Glaukos, cutting an estimated $40.2M.
  • Frazier Management's ten largest holdings make up 100% of its $125M portfolio in Q2 2016.
  • Frazier Management opened 1 new position and closed 0 in Q2 2016.
  • Frazier Management's portfolio value fell 23% quarter-over-quarter to $125M.

Based on Frazier Management's 13F filing for Q2 2016, filed 9 Aug 2016.